Cormorant Asset Management, LP Edgewise Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

$992 Million
Q2 2025

A detailed history of Cormorant Asset Management, LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 4,251,992 shares of EWTX stock, worth $78.1 Million. This represents 5.62% of its overall portfolio holdings.

Number of Shares

4,251,992

Previous 4,101,992 3.66%

Holding current value

$78.1 Million

Previous $90.2 Million 38.23%

% of portfolio

5.62%

Previous 9.57%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$11.42 - $20.13 $1.71 Million - $3.02 Million	150,000 Added 3.66%	4,251,992 $55.7 Million
Q1 2025 May 15, 2025	BUY	$22.0 - $30.03 $15.3 Million - $20.9 Million	695,458 Added 20.42%	4,101,992 $90.2 Million
Q3 2024 Nov 14, 2024	BUY	$15.88 - $29.5 $6.35 Million - $11.8 Million	400,000 Added 13.3%	3,406,534 $90.9 Million
Q1 2024 May 15, 2024	BUY	$9.25 - $19.97 $4.2 Million - $9.08 Million	454,545 Added 17.81%	3,006,534 $54.8 Million
Q4 2023 Feb 14, 2024	SELL	$5.51 - $12.1 $2.18 Million - $4.78 Million	-394,898 Reduced 13.4%	2,551,989 $27.9 Million
Q4 2022 Feb 14, 2023	SELL	$7.58 - $11.08 $796,673 - $1.16 Million	-105,102 Reduced 3.44%	2,946,887 $26.3 Million
Q3 2022 Nov 14, 2022	SELL	$8.08 - $13.58 $6.45 Million - $10.8 Million	-798,011 Reduced 20.73%	3,051,989 $30 Million
Q2 2022 Aug 15, 2022	SELL	$5.67 - $9.87 $4.72 Million - $8.22 Million	-832,874 Reduced 17.79%	3,850,000 $30.6 Million
Q1 2022 May 16, 2022	BUY	$9.1 - $18.97 $10.2 Million - $21.2 Million	1,116,973 Added 31.32%	4,682,874 $45.4 Million
Q4 2021 Feb 14, 2022	BUY	$14.41 - $22.41 $2.81 Million - $4.37 Million	194,987 Added 5.78%	3,565,901 $54.5 Million
Q3 2021 Nov 15, 2021	BUY	$14.11 - $24.1 $3.25 Million - $5.54 Million	230,000 Added 7.32%	3,370,914 $56 Million
Q2 2021 Aug 16, 2021	BUY	$21.33 - $30.25 $17.1 Million - $24.2 Million	800,000 Added 34.17%	3,140,914 $66.5 Million
Q1 2021 May 17, 2021	BUY	$30.0 - $35.99 $70.2 Million - $84.2 Million	2,340,914 New	2,340,914 $74.3 Million

Others Institutions Holding EWTX

# of Institutions

192

Shares Held

118M

Call Options Held

54.3K

Put Options Held

70.1K

View Full List

About Edgewise Therapeutics, Inc.

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.16B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

More about EWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Edgewise Therapeutics, Inc. Transaction History